Because our in vitro results confirmed that ANXA2 promoted proliferation by regulating GPC1, we speculated that GPC1 overexpression in glioma may be attributed to the dysregulated expression of ANXA2. The gene discussed is GPC1; the disease is central nervous system cancer.